FDA Inspection 1064451 — Orthority Corporation

Orthority Corporation — FEI 3008961297

The FDA completed an inspection of Orthority Corporation on Aug 14, 2018 in Caguas, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 14, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Caguas, PR (United States)